or
Sign in to turn on 1-Click ordering.
or
Amazon Prime Free Trial required. Sign up when you check out. Learn More
Kindle Edition
Read instantly on your iPad, PC or Mac, no Kindle required
Buy Price: $81.60
Rent From: $37.46
 
 
   
More Buying Choices
Have one to sell? Sell yours here
Target Validation in Drug Discovery
 
 

Target Validation in Drug Discovery [Hardcover]

Brian W. Metcalf (Editor), Susan Dillon (Editor)

Price: $102.00 & this item ships for FREE with Super Saver Shipping. Details
  Special Offers Available
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.
Only 2 left in stock--order soon (more on the way).
Want it delivered Monday, January 30? Choose One-Day Shipping at checkout. Details
Textbook Student FREE Two-Day Shipping for Students. Learn more

Formats

Amazon Price New from Used from
Kindle Edition
Rent from
$81.60
$37.46
 
Hardcover $102.00  

Book Description

0123693934 978-0123693938 October 6, 2006 1
This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as "second generation" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book.

Special Offers and Product Promotions

  • Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)

Editorial Reviews

From the Back Cover

The sequencing of the human genome has offered a genetic description of the entire repertoire of human genes, including a subset of disease targets. Despite this knowledge, now publically available, clinical pipelines are not yet enriched in drugs derived from targets emanating from this massive sequencing effort. A major concern for researchers in the biotechnology and pharmaceutical industries is how to choose the most likely targets for drug discovery and how to validate them.

Target Validation in Drug Discovery describes the background for the choice of target for several successful biological drugs (protein therapeutics). It offers excellent analyses of the underlying biology, the establishment of relative assays, and the translation to clinical trials of these drugs. Professionals in biotechnology and pharmaceutical drug discovery, clinical development, students, and academics in related areas of study will find this a unique reference for years to come.

. Includes detailed descriptions of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics
. Takes a look at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin
. Additional targets known as "second generation" drugs are covered and present new possible small molecule therapeutics
. Details approaches to design of orally active drugs against new disease mechanisms
. Contains contemporary technologies in drug discovery and case histories of successful drugs

Product Details


Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Inside This Book (learn more)
Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
cetuximab therapy, inactivation cassette, cetuximab treatment, gatekeeper pocket, gene trap event, trastuzumab resistance, gene targeting projects, trapped gene, infliximab maintenance therapy, target validation studies, trastuzumab therapy, kinase selectivity, gene trapping, tissue influx, gene trap vector, trapping component, growth factor receptor monoclonal antibody, homology arms, growth factor receptor antibody, lamina propria mononuclear cells, gene knockdown, antibody cetuximab, selection cassette, macrophage influx, targeting efficiency
Key Phrases - Capitalized Phrases (CAPs): (learn more)
Cancer Res, Academic Press, Kidney Int, Cancer Inst, Drug Discovery Copyright, Cell Biol, New York, Arthritis Rheum, United States, Genes Dev, Humana Press Inc, Lippincott Williams, Cancer Biol, Cell Res, Cytokine Netw, Hirata Terra, Hrabe de Angelis, Trends Biochem
New!
Books on Related Topics | Concordance | Text Stats
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Surprise Me!
Search Inside This Book:



Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject